Technological Advancements in Veterinary Antimicrobial Susceptibility Testing bioMérieux's VITEK MS PRIME Receives FDA Clearance Trend: A Crucial Influence on the Veterinary Antimicrobial Susceptibility Testing Market's Transformation in 2025

Which drivers are expected to have the greatest impact on the over the veterinary antimicrobial susceptibility testing market's growth?
The veterinary antimicrobial susceptibility testing market is anticipated to grow due to the escalating frequency of zoonotic diseases. A zoonotic disease constitutes an infectious disease that humans can contract from other animals and vice versa. The surge in such diseases necessitates the need for testing to ascertain the most effective animal drugs. Veterinary antimicrobial susceptibility testing assists in selecting the most optimal medication to curb bacterial infections in animals, informed by past treatments among other factors. For instance, in July 2022, the World Health Organization reported that there was a 64% increase in zoonotic cases in Africa, as pointed out by a US government agency. Additionally, there is a notable surge in zoonotic diseases both globally and in India. Such emerging infectious diseases account for 60% of human cases, with a sizable 816 out of 1407 human pathogens being zoonotic. Hence, the escalating frequency of zoonotic diseases is a major factor propelling the growth of the veterinary antimicrobial susceptibility testing market.

Get Your Veterinary Antimicrobial Susceptibility Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/veterinary-antimicrobial-susceptibility-testing-global-market-report

What is the future CAGR of the veterinary antimicrobial susceptibility testing market, and how will it impact industry expansion?
In recent times, the market size of veterinary antimicrobial susceptibility testing has seen robust growth. The market is set to increase from $37.12 billion in 2024 to $39.71 billion in 2025, registering a compound annual growth rate (CAGR) of 7.0%. Factors such as environmental considerations, the need for precision medicine, the one health approach, consumer awareness, and the rise in companion animal healthcare have contributed to this growth during the historical period.

Over the following years, the veterinary antimicrobial susceptibility testing market is predicted to experience robust expansion. The market is projected to increase to $53.96 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. The anticipated growth during the forecasted period can be credited to factors such as mitigation of antibiotic resistance, regulatory demands, influence of global health events, and a rise in pet ownership. The forecast period also highlights major trends such as innovative solutions, regulatory focus, control of zoonotic diseases, and standards in the livestock industry.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp

What are the most significant trends transforming the veterinary antimicrobial susceptibility testing market today?
The advent of technological innovations has become a key trend gaining momentum in the veterinary antimicrobial susceptibility testing market. Major industry players are focusing on the development of new technologies to maintain their market standing. The market has recently seen the application of advanced imaging methods and algorithms for more precise, dependable, and swift veterinary AST (antimicrobial susceptibility testing). For example, in March 2022, bioMérieux, a biotechnology organization based in France, was granted FDA 510(k) clearance for its new VITEK MS PRIME, a MALDI- TOF1 type mass spectrometry identification system. Following the receipt of the FDA 510(k) clearance, the system is now available for commercial use in countries that recognize CE-marking, as well as in the United States. It provides rapid and accurate identification of pathogens, promoting quicker and more pinpointed antimicrobial therapy.

Which key market segments comprise the veterinary antimicrobial susceptibility testing market and drive its revenue growth?
The veterinary antimicrobial susceptibility testing market covered in this report is segmented -

1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments
2) By Animal Type: Livestock Animals, Companion Animals
3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users

Subsegments:
1) By Disks And Plates: Antibiotic Disks, Agar Plates
2) By Culture Media: Selective Culture Media, General Purpose Media
3) By Accessories And Consumables: Incubators, Sterilization Equipment, Pipettes And Reagents
4) By Automated AST (Antimicrobial Susceptibility Test) Instruments: Fully Automated Systems, Semi-Automated Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8177

What regions are at the forefront of veterinary antimicrobial susceptibility testing market expansion?
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2024. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the veterinary antimicrobial susceptibility testing market?
Major companies operating in the veterinary antimicrobial susceptibility testing market are BioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, IDEXX Laboratories Inc., Merck Co. & KGaA, Microbiologics Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp

What Is Covered In The Veterinary Antimicrobial Susceptibility Testing Global Market Report?

• Market Size Forecast: Examine the veterinary antimicrobial susceptibility testing market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the veterinary antimicrobial susceptibility testing market for a structured understanding.
• Key Players Overview: Analyze major players in the veterinary antimicrobial susceptibility testing market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the veterinary antimicrobial susceptibility testing market.
• Segment Contributions: Evaluate how different segments drive overall growth in the veterinary antimicrobial susceptibility testing market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the veterinary antimicrobial susceptibility testing market.
• Industry Challenges: Identify potential risks and obstacles affecting the veterinary antimicrobial susceptibility testing market.
• Competitive Landscape: Review strategic developments in the veterinary antimicrobial susceptibility testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.